Table 8 Comparison of demographic data for patients with recurrence of subretinal fluid, after photodynamic therapy, between the two treatment groups
Demographic (N=15) | Half-dose PDT group (n = 7eyes/ 5patients) | One-third-dose PDT group (n = 8eyes/7 patients) | P-Value |
|---|---|---|---|
Age mean±sd (years) | 52.00±6.44 | 48.14±9.99 | 0.469 |
Sex,No.(%) | |||
Male | 5 (100) | 7 (100) | – |
Female | 0 (0.0) | 0 (0.0) | |
Study eye, No. (%) | |||
RE | 4 (57.1) | 3 (37.5) | 0.619 |
LE | 3 (42.9) | 5 (62.5) | |
BMI,mean±sd,kg/m2 | 23.81±6.85 | 24.99±3.30 | 0.697 |
duration of symptom, mean±sd, (months) | 15.00±11.59 | 16.25±8.69 | 0.815 |
Group Type | |||
recurrent | 0 (0.0) | 3 (37.5) | 0.200 |
chronic recurrent | 7 (100) | 5 (62.5) | |
Leakage type, No. (%) | |||
Smoke stack | 0 (0.0) | 1 (12.5) | 0.348 |
Ink blot | 2 (28.6) | 4 (50.0) | |
Diffuse | 5 (71.4) | 3 (37.5) | |
GLP (mean±sd) | 2187.14±1901.31 | 2339.00±1457.98 | 0.864 |
PDT spot size, (mean±sd) | 3514.29±2132.62 | 3638.38±2080.62 | 0.911 |
Initial BCVA | |||
LogMAR, (mean±sd) | 0.62±0.38 | 0.30±0.33 | 0.099 |
Initial CRT, (mean±sd) | 321.00±135.67 | 288.25±60.02 | 0.546 |